Strategic Partnerships Ra Pharmaceuticals, now under UCB, has expanded its market reach through recent partnerships with Inhealthcare and CBC Group, indicating potential opportunities for cross-selling UCB's pharmaceutical products and services to partners' networks.

Innovative Digital Health Solutions The development of a digital health platform and programs like FASTRAX by UCB presents a sales opportunity to offer tech-driven healthcare solutions to healthcare providers, leveraging UCB's expertise in the pharmaceutical industry.

Clinical Toolkits Development UCB's collaboration to develop a Clinical Toolkit for Preventing Epilepsy Deaths showcases its commitment to addressing critical health issues, offering a sales avenue to promote these toolkits to healthcare organizations looking to enhance patient care and safety measures.

Market Expansion in China UCB's sale of assets and mature businesses to CBC Group and Mubadala in China indicates a growing presence in the Chinese pharmaceutical market, creating potential sales opportunities for UCB to introduce its products and services to a wider audience.

Employee Engagement Initiatives The recognition of UCB's work with an Emmy Award and the development of impactful podcasts not only enhance brand visibility but also provide a platform to showcase UCB's values and products, paving the way for sales engagement based on shared social responsibility and corporate ethos.